Results 11 to 20 of about 425,528 (280)
The Lancet, 2009 This issue of eMedRef provides information to clinicians on the pathophysiology, diagnosis, and therapeutics of renal cell ...
Hermiston, Jennet
core +6 more sources
Simultaneous Chromophobe renal cell carcinoma and squamous renal cell carcinoma [PDF]
Diagnostic Pathology, 2007 Chromophobe renal cell carcinoma (CHRC) is a neoplasm of the kidney with clinicopathologic peculiarities that seems to be of better prognosis than conventional renal cell carcinoma.
Robles Luis +4 more
doaj +4 more sources
Nature Reviews Disease Primers, 2017 Renal cell carcinoma (RCC) denotes cancer originated from the renal epithelium and accounts for >90% of cancers in the kidney. The disease encompasses >10 histological and molecular subtypes, of which clear cell RCC (ccRCC) is most common and accounts for most cancer-related deaths. Although somatic VHL mutations have been described for some time, more-
Hsieh, James J. +8 more
openaire +8 more sources
Cancer Biomarkers, 2011 Renal Cell Carcinoma (RCC) has the highest mortality rate of the genitourinary cancers and the incidence of RCC has risen steadily. If detected early, RCC is curable by surgery although a minority are at risk of recurrence. Increasing incidental detection and an ageing population has led to active surveillance as an option for patients with small renal
openaire +6 more sources
Current Opinion in Oncology, 1997 Renal cell carcinoma remains a major challenge for urologic oncologists. Over the past year, progress has been made in understanding the molecular biology of this disease and in describing new prognostic factors for outcome following nephrectomy. Studies have better defined patients who might benefit from elective nephron-sparing procedures without ...
David M. Nanus +7 more
+10 more sources
BMJ, 2014 The treatment of renal cell carcinoma (RCC) has changed greatly over the past 15 years. Progress in the surgical management of the primary tumor and increased understanding of the molecular biology and genomics of the disease have led to the development of new therapeutic agents.
W. Kimryn Rathmell +2 more
openaire +3 more sources
Effects of phlebotomy on the growth of ferric nitrilotriacetate-induced renal cell carcinoma. [PDF]
, 2002 The ferric nitrilotriacetate-induced carcinogenesis model is unique in that reactive oxygen species-free radicals are involved in the carcinogenic process.
Fujisawa, Masayoshi +5 more
core +1 more source
BMC Urology, 2013 Background Papillary renal cell carcinoma is a rare cancer. Some cases can be attributed to individuals with hereditary renal cell carcinomas usually consisting of the clear cell subtype.
Behnes Carl Ludwig +7 more
doaj +1 more source
Upper Tract Urothelial Tumor with Renal Vein and Inferior Vena Cava Thrombus Case Report [PDF]
, 2017 Introduction: Urothelial tumors of upper tract are uncommon in clinical practice compared to other renal malignancy. Presentation of Case: A 71-year-old man with multiple co-morbidities who presented with generalized non-specific symptoms was worked up ...
Raed A, Alturki A
core +1 more source
World Journal of Urology, 2016 Renal cell cancer (RCC) accounts for approximately 2–3 % of all human malignancies and shows a worldwide increase of incidence rate of 2 % per year [1]. It primarily affects men and women at the age of 50–70 years with a twofold higher incidence rate in men.
Börje Ljungberg +2 more
openaire +3 more sources